Florida Newswire
US Kidney Research Corp Advances Toward Implantable Artificial Kidney : National News
By
Waterless technology can replace dialysis and transform kidney treatment
ROSEVILLE, Calif., March 13, 2025 (SEND2PRESS NEWSWIRE) — US Kidney Research Corporation (USKRC) is creating the world’s first waterless blood purification device, a pioneering technology with the capability to replace traditional dialysis machines worldwide. A recent groundbreaking discovery in the design of the device’s ion transport system, a critical component responsible for removing excess ions from the bloodstream, restoring ion balance, and directing these excess elements to the urine, is significantly accelerating progress and bringing the device closer to completion. The ion transport system plays a vital role in maintaining essential physiological functions. For individuals with kidney disease, the kidneys often fail to filter out excess ions such as sodium, potassium, and phosphorus, causing dangerous imbalances that can lead to serious health issues. Reaching this milestone brings US Kidney Research Corporation closer to its ultimate goal of developing an implantable artificial kidney. A waterless device is crucial for the development of an implantable artificial kidney. Dialysis’s reliance on a constant water and dialysate supply makes miniaturization and implantation within the body impossible. This achievement marks a historic milestone as the first successful development of a waterless ion transport system for a medical blood purification device, something that has never been accomplished before. CEO Roland Ludlow stated, “Creating an ion transport system is an extremely complex scientific challenge. After years of research and extensive experimentation, our scientists have discovered the method needed to complete the task. Breaking through this barrier is a major leap forward.”
Waterless Advantages: In contrast to traditional dialysis systems that depend on water, disposable components like dialyzers and dialysate solutions, as well as a separate water purification infrastructure, the waterless blood purifying device eliminates the need for these costly items, offering significant savings for healthcare providers. Additionally, the device will incorporate innovative technology, such as real-time patient monitoring and precise control over electrolyte, urea, and fluid removal, ensuring greater accuracy and better outcomes for patients. Ecological Benefits: The waterless blood purifying device addresses environmental challenges by reducing the carbon footprint. It will greatly reduce the billions of gallons of contaminated water generated by dialysis, minimize dialyzer plastic waste, and lower transport and energy costs associated with production. MISSION & GOALS
Completing its flagship waterless blood purifying device to replace outdated dialysis machines. Developing an implantable artificial kidney using the same waterless technology. Progressing several related renal care products currently in development. EXPERT COLLABORATION
US Kidney Research Corporation’s innovations are backed by a distinguished research team from the University of Arkansas (UA) and Dr. Ira Kurtz, the Chief of Nephrology at UCLA, who serves as the Corporation’s science/medical advisor and active board member. Dr. Kurtz, a leading expert in kidney disease, works alongside Dr. Jamie Hestekin and the UA team to drive progress toward a viable, long-term solution for kidney disease patients. ABOUT US:
US Kidney Research Corporation (USKRC) is at the forefront of artificial kidney research and development. Acknowledged by leading organizations such as the American Society of Nephrology (ASN), KidneyX, and the US Department of Health and Human Services (HHS), USKRC is transforming the future of kidney care. By pioneering new standards in treatment, USKRC is bringing hope for a future beyond dialysis. Established in 2015, USKRC is registered as a C-Corporation in Delaware.

US Kidney Research Corp Advances Toward Implantable Artificial Kidney : National News

| CitizenWire
Waterless technology can replace dialysis and transform kidney treatment
ROSEVILLE, Calif. /CitizenWire/ -- US Kidney Research Corporation (USKRC) is creating the world's first waterless blood purification device, a pioneering technology with the capability to replace traditional dialysis machines worldwide. A recent groundbreaking discovery in the design of the device's ion transport system, a critical component responsible for removing excess ions from the bloodstream, restoring ion balance, and directing these excess elements to the urine, is significantly accelerating progress and bringing the device closer to completion. The ion transport system plays a vital role in maintaining essential physiological functions. For individuals with kidney disease, the kidneys often fail to filter out excess ions such as sodium, potassium, and phosphorus, causing dangerous imbalances that can lead to serious health issues. Reaching this milestone brings US Kidney Research Corporation closer to its ultimate goal of developing an implantable artificial kidney. A waterless device is crucial for the development of an implantable artificial kidney. Dialysis's reliance on a constant water and dialysate supply makes miniaturization and implantation within the body impossible. This achievement marks a historic milestone as the first successful development of a waterless ion transport system for a medical blood purification device, something that has never been accomplished before. CEO Roland Ludlow stated, "Creating an ion transport system is an extremely complex scientific challenge. After years of research and extensive experimentation, our scientists have discovered the method needed to complete the task. Breaking through this barrier is a major leap forward." Waterless Advantages: In contrast to traditional dialysis systems that depend on water, disposable components like dialyzers and dialysate solutions, as well as a separate water purification infrastructure, the waterless blood purifying device eliminates the need for these costly items, offering significant savings for healthcare providers. Additionally, the device will incorporate innovative technology, such as real-time patient monitoring and precise control over electrolyte, urea, and fluid removal, ensuring greater accuracy and better outcomes for patients. Ecological Benefits: The waterless blood purifying device addresses environmental challenges by reducing the carbon footprint. It will greatly reduce the billions of gallons of contaminated water generated by dialysis, minimize dialyzer plastic waste, and lower transport and energy costs associated with production. MISSION & GOALS
* Completing its flagship waterless blood purifying device to replace outdated dialysis machines. * Developing an implantable artificial kidney using the same waterless technology. * Progressing several related renal care products currently in development. EXPERT COLLABORATION
US Kidney Research Corporation's innovations are backed by a distinguished research team from the University of Arkansas (UA) and Dr. Ira Kurtz, the Chief of Nephrology at UCLA, who serves as the Corporation's science/medical advisor and active board member. Dr. Kurtz, a leading expert in kidney disease, works alongside Dr. Jamie Hestekin and the UA team to drive progress toward a viable, long-term solution for kidney disease patients. ABOUT US:
US Kidney Research Corporation (USKRC) is at the forefront of artificial kidney research and development. Acknowledged by leading organizations such as the American Society of Nephrology (ASN), KidneyX, and the US Department of Health and Human Services (HHS), USKRC is transforming the future of kidney care. By pioneering new standards in treatment, USKRC is bringing hope for a future beyond dialysis. Established in 2015, USKRC is registered as a C-Corporation in Delaware. Learn more: https://www.uskidneyresearchcorp.com/
This version of news story was published on and is Copr. © 2025 CitizenWire™ ( CitizenWire.com ) - part of the Neotrope® News Network, USA - all rights reserved. Information is believed accurate but is not guaranteed. For questions about the above news, contact the company/org/person noted in the text and NOT this website. About Roderick Kinnison

News: US Kidney Research Corp Advances Toward Implantable Artificial Kidney | CitizenWire

| National News
By
Waterless technology can replace dialysis and transform kidney treatment
ROSEVILLE, Calif. /California Newswire – National News/ — US Kidney Research Corporation (USKRC) is creating the world’s first waterless blood purification device, a pioneering technology with the capability to replace traditional dialysis machines worldwide. A recent groundbreaking discovery in the design of the device’s ion transport system, a critical component responsible for removing excess ions from the bloodstream, restoring ion balance, and directing these excess elements to the urine, is significantly accelerating progress and bringing the device closer to completion. The ion transport system plays a vital role in maintaining essential physiological functions. For individuals with kidney disease, the kidneys often fail to filter out excess ions such as sodium, potassium, and phosphorus, causing dangerous imbalances that can lead to serious health issues. Reaching this milestone brings US Kidney Research Corporation closer to its ultimate goal of developing an implantable artificial kidney. A waterless device is crucial for the development of an implantable artificial kidney. Dialysis’s reliance on a constant water and dialysate supply makes miniaturization and implantation within the body impossible. This achievement marks a historic milestone as the first successful development of a waterless ion transport system for a medical blood purification device, something that has never been accomplished before. CEO Roland Ludlow stated, “Creating an ion transport system is an extremely complex scientific challenge. After years of research and extensive experimentation, our scientists have discovered the method needed to complete the task. Breaking through this barrier is a major leap forward.”
Waterless Advantages: In contrast to traditional dialysis systems that depend on water, disposable components like dialyzers and dialysate solutions, as well as a separate water purification infrastructure, the waterless blood purifying device eliminates the need for these costly items, offering significant savings for healthcare providers. Additionally, the device will incorporate innovative technology, such as real-time patient monitoring and precise control over electrolyte, urea, and fluid removal, ensuring greater accuracy and better outcomes for patients. Ecological Benefits: The waterless blood purifying device addresses environmental challenges by reducing the carbon footprint. It will greatly reduce the billions of gallons of contaminated water generated by dialysis, minimize dialyzer plastic waste, and lower transport and energy costs associated with production. MISSION & GOALS
* Completing its flagship waterless blood purifying device to replace outdated dialysis machines. * Developing an implantable artificial kidney using the same waterless technology. * Progressing several related renal care products currently in development. EXPERT COLLABORATION
US Kidney Research Corporation’s innovations are backed by a distinguished research team from the University of Arkansas (UA) and Dr. Ira Kurtz, the Chief of Nephrology at UCLA, who serves as the Corporation’s science/medical advisor and active board member. Dr. Kurtz, a leading expert in kidney disease, works alongside Dr. Jamie Hestekin and the UA team to drive progress toward a viable, long-term solution for kidney disease patients. ABOUT US:
US Kidney Research Corporation (USKRC) is at the forefront of artificial kidney research and development. Acknowledged by leading organizations such as the American Society of Nephrology (ASN), KidneyX, and the US Department of Health and Human Services (HHS), USKRC is transforming the future of kidney care. By pioneering new standards in treatment, USKRC is bringing hope for a future beyond dialysis. Established in 2015, USKRC is registered as a C-Corporation in Delaware.

US Kidney Research Corp Advances Toward Implantable Artificial Kidney | National News

Massachusetts Newswire
US Kidney Research Corporation Advances Toward Implantable Artificial Kidney to Replace Dialysis
By
Waterless technology can replace dialysis and transform kidney treatment
ROSEVILLE, Calif. /Massachusetts Newswire – National News/ — US Kidney Research Corporation (USKRC) is creating the world’s first waterless blood purification device, a pioneering technology with the capability to replace traditional dialysis machines worldwide. A recent groundbreaking discovery in the design of the device’s ion transport system, a critical component responsible for removing excess ions from the bloodstream, restoring ion balance, and directing these excess elements to the urine, is significantly accelerating progress and bringing the device closer to completion. The ion transport system plays a vital role in maintaining essential physiological functions. For individuals with kidney disease, the kidneys often fail to filter out excess ions such as sodium, potassium, and phosphorus, causing dangerous imbalances that can lead to serious health issues. Reaching this milestone brings US Kidney Research Corporation closer to its ultimate goal of developing an implantable artificial kidney. A waterless device is crucial for the development of an implantable artificial kidney. Dialysis’s reliance on a constant water and dialysate supply makes miniaturization and implantation within the body impossible. This achievement marks a historic milestone as the first successful development of a waterless ion transport system for a medical blood purification device, something that has never been accomplished before. CEO Roland Ludlow stated, “Creating an ion transport system is an extremely complex scientific challenge. After years of research and extensive experimentation, our scientists have discovered the method needed to complete the task. Breaking through this barrier is a major leap forward.”
Waterless Advantages: In contrast to traditional dialysis systems that depend on water, disposable components like dialyzers and dialysate solutions, as well as a separate water purification infrastructure, the waterless blood purifying device eliminates the need for these costly items, offering significant savings for healthcare providers. Additionally, the device will incorporate innovative technology, such as real-time patient monitoring and precise control over electrolyte, urea, and fluid removal, ensuring greater accuracy and better outcomes for patients. Ecological Benefits: The waterless blood purifying device addresses environmental challenges by reducing the carbon footprint. It will greatly reduce the billions of gallons of contaminated water generated by dialysis, minimize dialyzer plastic waste, and lower transport and energy costs associated with production. MISSION & GOALS
* Completing its flagship waterless blood purifying device to replace outdated dialysis machines. * Developing an implantable artificial kidney using the same waterless technology. * Progressing several related renal care products currently in development. EXPERT COLLABORATION
US Kidney Research Corporation’s innovations are backed by a distinguished research team from the University of Arkansas (UA) and Dr. Ira Kurtz, the Chief of Nephrology at UCLA, who serves as the Corporation’s science/medical advisor and active board member. Dr. Kurtz, a leading expert in kidney disease, works alongside Dr. Jamie Hestekin and the UA team to drive progress toward a viable, long-term solution for kidney disease patients. ABOUT US:
US Kidney Research Corporation (USKRC) is at the forefront of artificial kidney research and development. Acknowledged by leading organizations such as the American Society of Nephrology (ASN), KidneyX, and the US Department of Health and Human Services (HHS), USKRC is transforming the future of kidney care. By pioneering new standards in treatment, USKRC is bringing hope for a future beyond dialysis. Established in 2015, USKRC is registered as a C-Corporation in Delaware.

US Kidney Research Corporation Advances Toward Implantable Artificial Kidney to Replace Dialysis

Global Artificial Kidney Market was valued at USD 0.2 billion in 2023. It is expected to reach USD 21.2 billion by 2033, with a CAGR of 61.3%  In 2023, Wearable Artificial Kidney held a dominant market position in the By Device Type segment of the Artificial Kidney Market, capturing more than a 60% share.”  — Tajammul Pangarkar NEW YORK, NY, UNITED STATES, February 21, 2025 / EINPresswire.com / -- Overview  The Global Artificial Kidney Market was valued at USD 0.2 billion in 2023. It is expected to reach USD 21.2 billion by 2033, with a CAGR of 61.3% during the forecast period from 2024 to 2033.  The development of the artificial kidney marks a significant advancement in renal disease treatment, offering a potential alternative to dialysis and kidney transplants. Designed to replicate the natural functions of a human kidney, this innovation aims to filter waste, balance electrolytes, and regulate fluid levels in patients with end-stage renal disease (ESRD).  Unlike traditional dialysis, which requires frequent hospital visits, artificial kidney technology is being developed as an implantable or wearable device, providing continuous blood filtration. Researchers are exploring bioengineered kidney tissues and advanced nanotechnology filters to enhance efficiency and compatibility with the human body.  The artificial kidney is expected to reduce dependency on donor transplants, addressing the global organ shortage crisis. Early trials indicate promising results in maintaining stable blood filtration, with ongoing studies ensuring long-term safety and effectiveness.  This breakthrough holds immense potential for millions of kidney disease patients worldwide, improving quality of life and survival rates. As research progresses, regulatory approvals and commercial production are anticipated to revolutionize renal healthcare, bringing hope to those suffering from chronic kidney conditions.  Click here to get a Sample report copy @ https://marketresearch.biz/report/artificial-kidney-market/request-sample/  Key Takeaways  •Market Growth: The global artificial kidney market was valued at USD 0.2 billion in 2023 and is projected to grow significantly, reaching USD 21.2 billion by 2033, with an impressive CAGR of 61.3% from 2024 to 2033.  •By Device Type: Wearable Artificial Kidneys lead the market, holding a 60% share, driven by their potential to provide continuous blood filtration and improve patient mobility.  •- By End User: Hospitals remain the primary users, accounting for 65% of the market, due to their role in advanced kidney disease management and transplant procedures.  •Regional Dominance: North America leads with a 30.3% market share, supported by a strong healthcare infrastructure and extensive research in renal replacement therapies.  •Growth Opportunity: Market expansion is fueled by technological advancements in wearable artificial kidneys and the growth of renal replacement therapy centers, enhancing patient access and treatment efficiency worldwide.  Segmentation Analysis  By Device Type Analysis: Wearable Artificial Kidneys held a 60% market share in 2023, driven by the increasing prevalence of chronic kidney disease (CKD) and the demand for portable dialysis solutions. These devices offer continuous ambulatory dialysis, enhancing patient mobility compared to traditional methods. Implantable Artificial Kidneys, still in development, aim to provide a permanent alternative to dialysis through advanced biomedical engineering and nanotechnology. Market growth is fueled by technological advancements, rising healthcare expenditure, and regulatory approvals, though high costs remain a challenge.  By End User Analysis: Hospitals dominated with a 65% market share, reflecting their role in advanced renal care and artificial kidney device management. Equipped with specialized healthcare professionals and infrastructure, hospitals are the primary centers for wearable and implantable artificial kidney treatments. Specialty Clinics also contribute significantly, offering focused nephrology treatments. Ambulatory Surgical Centers (ASCs) play a smaller role due to limited monitoring capacity. Hospital dominance is expected to continue, driven by technological integration and industry collaborations, improving patient outcomes and treatment efficiency.  Market Segments  By Device Type  •Wearable Artificial Kidney  •Implantable Artificial Kidney  By End User  •Hospitals  •Specialty Clinics  •Ambulatory Surgical Centers  To Purchase this Premium Report @ https://marketresearch.biz/purchase-report/?report_id=45912  Market Dynamics  •Driver: The artificial kidney market is primarily driven by the increasing prevalence of chronic kidney disease (CKD) worldwide. As the global dialysis population grows rapidly, especially in low- and middle-income countries, there is a substantial number of people lacking access to kidney replacement therapy, resulting in millions of deaths from kidney failure each year. This unmet need propels the demand for innovative solutions like artificial kidneys to provide effective and accessible treatment options.  •Trend: A significant trend in the artificial kidney market is the integration of advanced technologies such as 3D bioprinting and tissue engineering. Researchers are focusing on developing bioprinted kidneys to address the high demand for organ transplantation. This approach aims to reduce reliance on donor programs and increase the availability of suitable organs for transplantation, potentially transforming renal replacement therapies.  •Restraint: The artificial kidney market faces challenges related to the high costs associated with dialysis care and the inequitable access to treatment. The costs of dialysis care are high and will likely continue to rise as a result of increased life expectancy and improved therapies for causes of kidney failure such as diabetes mellitus and cardiovascular disease. This economic burden can hinder the widespread adoption of artificial kidney technologies, especially in resource-limited settings.  •Opportunity: Advancements in biogenerative engineering, particularly 3D bioprinting, present a promising opportunity in the artificial kidney market. The development of bioprinted kidneys could potentially address the organ shortage crisis, offering patients more timely and compatible transplantation options. This technological innovation has the potential to revolutionize kidney disease treatment by providing customized and readily available artificial organs.  Market Key Players  •Kawasumi Laboratories Inc.  •Blood Purification Technologies Inc.  •AWAK Technologies Pte. Ltd  •Trimmed AB  •Asahi Kasei Medical Vo. Ltd  •US Kidney Research Corporation  •Merit Medical Systems  •NIPRO Medical Corporation  •Fresenius SE & Co. KgaA  Regional Analysis  The Artificial Kidney Market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America, each exhibiting unique growth dynamics.  •North America leads the market with a 30.3% share, driven by advanced healthcare infrastructure, high healthcare spending, and a strong presence of key market players in the U.S. and Canada. A high prevalence of kidney diseases and an established organ transplant network further accelerate market expansion.  •Europe holds a significant position, supported by substantial investments in healthcare research and government-backed adoption of advanced technologies in countries such as Germany, France, and the UK.  •Asia Pacific is the fastest-growing region, fueled by improving healthcare facilities, rising awareness about kidney diseases, and increasing disposable income. Key contributors include China and India, where large patient pools and government-led healthcare reforms drive demand.  •The Middle East & Africa market is expanding with developing healthcare infrastructure and improved access to treatment. However, high treatment costs and limited awareness remain challenges.  •Latin America experiences steady growth, supported by gradual healthcare advancements and government efforts to improve kidney disease management in Brazil and Mexico.  Emerging Trends in Artificial Kidney Technology  •Implantable Bioartificial Kidneys: Researchers are developing implantable devices that mimic natural kidney functions, aiming to provide continuous blood filtration and reduce dependence on dialysis. These bioartificial kidneys combine filtration units with living kidney cells to replicate essential activities, such as hormone regulation and waste removal. This approach seeks to enhance patients' quality of life by offering a more integrated and efficient treatment option.  •Wearable Dialysis Devices: Advancements in miniaturization and nanotechnology have led to the creation of wearable dialysis machines. These portable devices allow patients to receive continuous treatment, improving mobility and lifestyle. By providing more frequent and consistent dialysis, wearable artificial kidneys aim to reduce complications associated with traditional methods and offer a more convenient solution for those with end-stage renal disease.  •Xenotransplantation Advances: The transplantation of genetically modified pig kidneys into humans has shown promising results. Recent cases have demonstrated the potential for these organs to function effectively in human recipients, addressing the shortage of human donor kidneys. This innovative approach could significantly reduce waiting times for transplants and offer a viable alternative for patients with chronic kidney disease.  Use Cases of Artificial Kidney Technology  •Patients with End-Stage Renal Disease (ESRD): In the United States, over 500,000 individuals require dialysis multiple times per week due to ESRD. Implantable artificial kidneys could eliminate the need for these frequent sessions, providing continuous blood filtration and improving overall quality of life. This advancement would reduce the burden on healthcare facilities and offer patients greater freedom and health outcomes.  •Individuals Ineligible for Traditional Transplants: Many patients are unable to receive human kidney transplants due to medical complications or a lack of suitable donors. For example, Towana Looney, a patient with high antibody levels, successfully received a genetically engineered pig kidney, functioning well beyond two months post-transplant. This case highlights the potential of xenotransplantation to provide life-saving options for those previously without viable treatments.  •Patients Seeking Improved Mobility and Lifestyle: Traditional dialysis often requires patients to adhere to strict schedules, limiting their daily activities. Wearable artificial kidneys offer a solution by allowing continuous treatment without confining patients to dialysis centers. This technology enables individuals to maintain their routines and enhances their independence, leading to better mental and physical health outcomes.  Explore More Healthcare Reports:  Interstitial Cystitis Market- https://marketresearch.biz/report/interstitial-cystitis-market/  Vegan Collagen Market- https://marketresearch.biz/report/vegan-collagen-market/  Acetaminophen Paracetamol Market- https://marketresearch.biz/report/acetaminophen-market/  Surgical Clips Market- https://marketresearch.biz/report/surgical-clips-market/  Contract Manufacturing Market- https://marketresearch.biz/report/contract-manufacturing-market/  Health Tourism Market- https://marketresearch.biz/report/health-tourism-market/  Elderly Care Market- https://marketresearch.biz/report/elderly-care-market/  Drug Addiction Treatment Market- https://marketresearch.biz/report/drug-addiction-treatment-market/  Immuno Oncology Market- https://marketresearch.biz/report/immuno-oncology-market/  Flu Treatment Market- https://marketresearch.biz/report/flu-treatment-market/  Lawrence John  Prudour   email us here  Legal Disclaimer:  EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Artificial Kidney Market Valued at USD 0.2 Billion in 2023, Set to Reach USD 21.2 Billion by 2033

US Kidney Research Corporation conducts research and development of artificial kidney technology within the healthcare sector. The company is working on a waterless artificial kidney that aims to provide alternatives to traditional dialysis and native kidney transplantation, with a focus on ultra-filter membrane technology. US Kidney Research Corporation targets the healthcare industry, specifically in renal therapy innovation. US Kidney Research Corporation was formerly known as Curion Research. It was founded in 2015 and is based in Roseville, California.

Date	Round	Amount	Investors	Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.	Revenue	Sources
10/22/2024	Unattributed - IX	$0.47M	Undisclosed Investors	$XXM	0 FY undefined	3
1/17/2023	Unattributed - VIII	$XXM	Subscribe to see more	$XXM	0 FY undefined	10
10/6/2020	Unattributed - VII	$XXM	Subscribe to see more	$XXM	0 FY undefined	10
2/25/2020	Unattributed - VI	$XXM	Subscribe to see more	$XXM	0 FY undefined	10
10/19/2018	Unattributed - V	$XXM	Subscribe to see more	$XXM	0 FY undefined	10

Date	10/22/2024	1/17/2023	10/6/2020	2/25/2020	10/19/2018
Round	Unattributed - IX	Unattributed - VIII	Unattributed - VII	Unattributed - VI	Unattributed - V
Amount	$0.47M	$XXM	$XXM	$XXM	$XXM
Investors	Undisclosed Investors	Subscribe to see more	Subscribe to see more	Subscribe to see more	Subscribe to see more
Valuation	$XXM	$XXM	$XXM	$XXM	$XXM
Revenue	0 FY undefined	0 FY undefined	0 FY undefined	0 FY undefined	0 FY undefined
Sources	3	10	10	10	10

How VCs Use CB Insights

Professional Services

Platform Overview

US Kidney Research Corporation

Total Raised

Funding, Valuation & Revenue